To measure the antibody decay after 2 BNT162b2 doses and the antibody response after a third vaccine dose administered 6 months after the second one in nursing home residents with and without prior COVID-19.
In Episode 2 of our two-part series, host Elizabeth Sobczyk, MSW, MPH, and special guest Leslie Eber, MD, CMD, share practical strategies for clinicians to enhance conversations about the COVID-19 vaccine and highlight leadership actions that have successfully increased vaccination rates in PALTC. We also ...
Workers in Medicare- or Medicaid-funded health-care provider organizations are now required by the Centers for Medicare & Medicaid Services (CMS) to be vaccinated against COVID-19 as a condition of participation in Medicare and Medicaid. Employees/ practitioners may request exemptions from such vaccine...
In December 2020, CDC launched the Pharmacy Partnership for Long-Term Care Program to facilitate COVID-19 vaccination of residents and staff in long-term care facilities (LTCFs), including assisted living (AL) and other residential care (RC) communities. We aimed to assess vaccine uptake in these communiti...
PALTmed’s Infection Advisory Committee has developed recommendations for the 2025–2026 COVID-19 vaccine to guide clinicians and administrators in post-acute and long-term care settings. While the CDC provides national guidance, these recommendations address the specific risks and needs of PALTC residents a...